z-logo
open-access-imgOpen Access
Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells
Author(s) -
Haitao Zhu,
Lirong Zhang,
Yanfang Liu,
Yuepeng Zhou,
Kang Wang,
Xiaodong Xie,
Song Lian,
Dongqing Wang,
Chunlei Han,
QiuYun Chen
Publication year - 2016
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/srep39245
Subject(s) - aptamer , magnetic resonance imaging , cancer research , in vivo , cancer cell , in vitro , hypoxia (environmental) , stem cell , dual mode , cancer stem cell , metastasis , tumor hypoxia , chemistry , cancer , medicine , microbiology and biotechnology , biology , biochemistry , radiation therapy , organic chemistry , aerospace engineering , oxygen , engineering , radiology
Hypoxia-induced cancer stem cells have been known to be involved in tumour metastasis, resistance to chemo/radio therapy and tumour recurrence. Magnetic Resonance Imaging is a widely used imaging tool for cancers in clinics and research. To develop T1-positive and T2-negative dual mode MRI agents for more comprehensive and accurate diagnostic information under hypoxic conditions, a hypoxia-inducible factor-1α based aptamer and Mn(II)-modified nanoparticles D-Fe 3 O 4 @PMn were synthesized and characterized. In vitro and in vivo studies show that D-Fe 3 O 4 @PMn NPs are biocompatible and less cytotoxic and can produce significant contrast enhancement in T1- and T2-weighted MR imaging. Furthermore, the D-Fe 3 O 4 @PMn NPs enable targeted dual-contrast T1- and T2-weighted MR imaging of cancer cells expressing high levels of HIF-1α and cancer stem cell-related proteins under hypoxic condition. In conclusion, NPs with HIF-1α and Mn(II) are promising diagnostic agents for dual-mode T1 and T2 imaging by targeting cancer stem cells as they are non-toxic and biocompatible.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom